C4 Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.24

+0.16 (+3.92%)

As of Aug 15, 2:11 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +825.5% upside

Low Target $29.92

Average Target $39.24

High Target $50.68

Current Price $4.24

Current
$4.24

Target
$39.24

$29.92 $39.24 avg $50.68

Scenario Analysis

Bear Case

$29.92

605.7%

Low target

Base Case

$39.24

+825.5%

Avg target

Bull Case

$50.68

+1,095.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$5.17

-18.0% from high

52-Week Low

$1.69

+150.9% from low

Target vs 52W High

$39.24

+659.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%